News
09-29-2012, 01:16 AM
In a new genetic study, researchers said they may have found a way to cut the cost of genetic screening for breast and ovarian cancers from $3000 to $400. Three teams of infertility scientists in New York and Austria collaborated to study gene mutations that increase a woman's likelihood of breast and ovarian cancers...
More... (http://www.medicalnewstoday.com/releases/250779.php)
More... (http://www.medicalnewstoday.com/releases/250779.php)